Honor and Solute the Veterans In Your Life

2018-11-09T15:30:13+00:00November 9th, 2018|Hot Topics|

By Rick Sherlock, Lung Cancer Alliance Board Member and retired Major General of the United States Army On this Veteran’s Day, we honor and salute the dedicated service of the brave men and women that protect our freedoms. In all they do for our country, it is our responsibility to protect them in the ways we know how. Due to higher smoking rates and exposure to environmental and chemical pollutants, military men and women, as well as veterans, have a [...]

LCA Urges CMS to Remove Barriers to Screening

2018-10-25T22:07:31+00:00October 25th, 2018|Hot Topics, News|

In a number of communications to the Centers for Medicare and Medicaid Services (CMS), Lung Cancer Alliance urged the national CMS office to 1) instruct all local Medicare contractors that lung cancer screening coverage is available in all settings including Independent Diagnostic Testing Facilities across the country and 2) provide oversight to these contractors that are erroneously denying lung cancer screening.  Low dose CT scans are a nationally covered preventive screening service available to Medicare beneficiaries in all settings. Lung [...]

Trial Results Show Screening Significantly Reduces Lung Cancer Mortality Rates

2018-09-25T16:03:13+00:00September 25th, 2018|Hot Topics, News|

Washington, DC [September 25, 2018] – Lung Cancer Alliance (LCA) applauds the results of the Dutch-Belgium Lung Cancer Screening trial (NELSON) announced today in Toronto, Canada at the IASLC 19th World Conference on Lung Cancer. The NELSON study was a population-based, controlled trial that enrolled 15,792 individuals, who were randomized 1:1 to either the study arm or control arm. Study arm participants were offered CT screenings at baseline, one, three and five and one-half years after randomization. No screenings were [...]

Meet Anita! Our Screening Expert

2018-06-28T13:11:32+00:00June 28th, 2018|Hot Topics, News|

By Anita McGlothlin, Associate Director of Science and Regulatory Policy, Lung Cancer Alliance Greetings! I am Anita McGlothlin, the Associate Director of Science and Regulatory Policy at Lung Cancer Alliance (LCA). I can’t wait to meet you in person at a future LCA event. In the interim, I’m excited to introduce and share a little bit about myself, my role at the LCA and what lung cancer advocacy means to me. Let’s start with some personal details - I am [...]

News Flash: Our Lungs Matter And Screening Does Save Lives

2018-05-23T15:22:54+00:00May 23rd, 2018|Hot Topics, News|

By Laurie Fenton Ambrose, President and CEO, Lung Cancer Alliance Make no mistake about it—lung cancer can be detected at an early stage, when it is more likely to be treatable and cured. Yes, you heard it right—treatable and cured. And not just for a handful of people, but for millions of people at risk. This is the message that the lung cancer community needs to hear right now—loud and clear—from all corners and at all levels of our medical [...]

My Public Health Path to Lung Cancer  

2018-04-06T21:01:02+00:00April 6th, 2018|Hot Topics|

By Amy Copeland, MPH, Director of Medical Outreach at Lung Cancer Alliance Public Health Week (April 2-9) got us thinking….What exactly is public health and how does it relate to lung cancer? We sat down with Amy Copeland, Lung Cancer Alliance’s (LCA) Director of Medical Outreach, who received her Masters of Public Health from George Washington University and has spent just shy of 20 years in the field, to ask these important questions, as well as learn a little about [...]

Lung Cancer Screening: What to Expect

2018-03-21T17:02:59+00:00February 7th, 2018|Hot Topics|

By Amy Copeland, MPH, Director of Medical Outreach with Lung Cancer Alliance Lung cancer screening. You may have seen it on the news or an advertisement for it, but what is it and does it make sense for you? Screening refers to a test for individuals considered to be at high risk for a disease before they have symptoms. Lung cancer often has no symptoms until it has spread due to a lack of pain receptors in the lungs. The [...]

VA-PALS – Improving Lung Cancer Screening For Our Veterans

2018-03-21T20:12:52+00:00January 25th, 2018|Hot Topics, News|

By: Angela Criswell, Senior Manager of Medical Outreach Lung cancer among veterans is a serious issue because they face higher incidence rates of the disease and lower survival rates compared with civilian populations. The disproportionate impact of lung cancer on veterans is due in part to higher smoking prevalence as well as occupational exposures including radon, asbestos and diesel exhaust among other known carcinogens. Because of the vital need for lung cancer early detection among veterans, Lung Cancer Alliance (LCA) [...]

LCA Participates in Inaugural Meeting of National Lung Cancer Roundtable

2018-03-21T20:41:11+00:00December 12th, 2017|Hot Topics, News|

Tuesday, December 12, 2017 – Today, Laurie Fenton Ambrose, President and CEO of Lung Cancer Alliance (LCA), along with a coalition of leading healthcare professionals, patients, government and non-governmental organizations, is joining the American Cancer Society for the inaugural meeting of the National Lung Cancer Roundtable. The event, taking place December 11 – 12, 2017 in Bethesda, Md., is a new, major collaboration to address the challenges associated with reducing lung cancer mortality by ensuring that the at-risk population has [...]

LCA Partners with Memorial Sloan Kettering Cancer Center and the New York University School of Medicine on CASTL Initiative

2018-03-23T15:27:23+00:00November 6th, 2017|Hot Topics, News|

Monday, November 6, 2017 – Today, Lung Cancer Alliance (LCA) joins the Memorial Sloan Kettering Cancer Center (MSK) and the NYU School of Medicine (NYU) to announce the launch of the Cessation And Screening To Save Lives (CASTL) Initiative. The project, which is supported by funding from the National Cancer Institute, will examine how to best leverage lung cancer screening to promote smoking cessation among individuals at high-risk for lung cancer. CASTL will be co-led by Jamie Ostroff, PhD, Chief [...]

No announcement available or all announcement expired.